Literature DB >> 33237558

CYP2C19 Genotype-Guided Antiplatelet Therapy Among Asian Patients with Ischaemic Stroke.

Chia Siang Kow1, Abdullah Faiz Zaihan2, Syed Shahzad Hasan3,4.   

Abstract

Entities:  

Year:  2020        PMID： 33237558     DOI： 10.1007/s40261-020-00985-5

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  2 in total

1.  Genetic polymorphisms and phenotypic analysis of drug-metabolizing enzyme CYP2C19 in a Li Chinese population.

Authors:  Yipeng Ding; Dongchuan Xu; Xiyang Zhang; Hua Yang; Tingting Geng; Ping He; Jinjian Yao; Shengyang Yi; Heping Xu; Duoyi Wu; Xiang Wang; Tianbo Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations.

Authors:  Kaavya Narasimhalu; Yoong Kwei Ang; Doreen Su Yin Tan; Deidre Anne De Silva; Kelvin Bryan Tan
Journal:  Clin Drug Investig       Date:  2020-11       Impact factor: 2.859
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.